iCardiac Technologies Honored at UNYTECH 2006

Venture Capital Forum Selects Company for Best Presentation Award

Rochester, New York – September 25, 2006 – iCardiac Technologies, Inc., a company based on technology developed at the University of Rochester specializing in cardiac safety analytics and biomarkers, announced today that it received the award for “Best Presentation” at UNYTECH 2006. The Universities of Upstate New York Venture Forum (UNYTECH) event took place on September 19th and 20th in Rochester, New York. The gathering featured young companies that are based on research from ten upstate-based universities.

UNYTECH brought together venture capitalists, seed and angel investors, as well as university officials, to learn about the most promising technologies and companies utilizing university research. The iCardiac Technologies presentation was delivered by Alex Zapesochny, the company’s President and Chief Operating Officer.

“We are very pleased to have been selected from so many excellent companies for this honor,” said Zapesochny. “It is exciting that iCardiac Technologies was singled out by the UNYTECH organizers based on the strength of our strategy and expansion plans.”

About iCardiac Technologies, Inc.

iCardiac Technologies, Inc., headquartered in Rochester, New York, is a leading provider of advanced cardiac safety analysis technologies. The company evolved from research carried out at the Heart Research Follow-up Program at the University of Rochester. The company’s technology provides more rigorous characterization of the cardiac safety profiles of in-development and on-market drugs. This allows iCardiac’s customers to both accelerate drug development as well as bring compounds forward in clinical trials with more confidence about their cardiac safety. Additionally, the company’s core technology has applications in ECG-based cardiac diagnostics and medical devices.

# # #